The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important ...

LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for ...

The capacity of household teaspoons ranges from 1.5 mL to 9 mL, potentially leading to errors in dosing. There are few studies evaluating alternative measuring devices. Objective: To assess adult ...

No dose adjustment is necessary for patients with ... Trial 3: An American trial comparing sorafenib plus gemcitabine or capecitabine versus gemcitabine or capecitabine plus placebo in MBC ...

Two new partial responses (PRs) reported in Phase 2a arm studying IMM-1-104 in combination with modified FOLFIRINOX (mFFX) in ...

Raritan: Johnson & Johnson has announced it has initiated the submission of an original New Drug Application with the U.S.

Invest in Arcus Biosciences for a strong buying opportunity with promising data, robust pipeline, and significant market ...

Each year, more than 853,000 people on Medicare use at least one of the 64 medications, according to the Centers for Medicare ...

- Two new partial responses (PRs) reported in Phase 2a arm studying IMM-1-104 in combination with modified FOLFIRINOX (mFFX) in first-line pancreatic cancer - - Overall Response Rate (ORR) of 50% ...

Advancing Multiple Programs in Areas of Significant Unmet Medical NeedSeveral Milestones Across Clinical Development Pipeline Expected in ...